Garadacimab (Anti-F12 / Factor XII)
Garadacimab (Anti-F12 / Factor XII) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research. MW: 145.5 KD.
| Trivial name | CSL312 |
| Catalog Number | A2503 |
| CAS# | 2162134-62-3 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/garadacimab-anti-f12-factor-xii.html |